Even if empirical therapy is defined as the agents used within 3 days of
bacteremia onset, the 30-day mortality rate of those receiving appropriate empirical therapy was significantly lower than that of those receiving inappropriate empirical
therapy (23.9%, 11/46 vs. 52.3%, 34/65; p Z 0.003).